NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Interest & Investment Income (2021 - 2023)

NeuroSense Therapeutics' (NRSN) quarterly Interest & Investment Income came in at -$5.8 million in Q4 2023, down 424.26% year-over-year from $1.8 million in Q4 2022, and down 242.25% quarter-over-quarter from $4.1 million in Q3 2023.

Analysis

NeuroSense Therapeutics (NRSN) Interest & Investment Income (2021 - 2023) Analysis & Trends

NeuroSense Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting -$5.8 million for Q4 2023.

  • In Q4 2023, Interest & Investment Income fell 424.26% year-over-year to -$5.8 million; the TTM figure through Dec 2023 stood at -$1.9 million (down 3032.26% YoY), while the FY2023 annual figure was -$1.9 million, down 3032.26% from the prior year.
  • Interest & Investment Income came in at -$5.8 million for Q4 2023 at NeuroSense Therapeutics, down from $4.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q3 2023 to a low of -$5.8 million in Q4 2023.
  • Average Interest & Investment Income over 3 years is $80555.6, with a median of $144000.0 recorded in 2022.
  • The largest YoY upside for Interest & Investment Income was 1124.48% in 2023 against a maximum downside of 424.26% in 2023.
  • Over 3 years, Interest & Investment Income stood at $2.7 million in 2021, then sank by 140.78% to -$1.1 million in 2022, then plunged by 424.26% to -$5.8 million in 2023.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were -$5.8 million in Q4 2023, $4.1 million in Q3 2023, and -$271000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -48.00 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 67.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 48.00 Mn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 36.92 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -5.84 Mn
Sep 30, 2023 4.10 Mn
Jun 30, 2023 -271,000.00
Mar 31, 2023 62,000.00
Dec 31, 2022 -1.11 Mn
Sep 30, 2022 335,000.00
Jun 30, 2022 144,000.00
Mar 31, 2022 572,000.00
Dec 31, 2021 2.73 Mn
API Access

NeuroSense Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRSN&period=max&api_key=YOUR_API_KEY